{"meta":{"status":200,"messages":[],"pagination":{"max":1,"offset":0,"count":1,"total":1,"pageNum":1,"totalPages":1,"sort":null,"currentUrl":"https://api.digitalmedia.hhs.gov/api/v2/resources/media.json?offset=0&max=1&ignoreHiddenMedia=1&format=json&id=12115&newUrlBase=http://www.cdc.gov/nceh/lead/programs","nextUrl":null,"previousUrl":null}},"results":[{"content":"
\nThe State of Michigan received $494,106 through cooperative agreement EH21-2102 from the Centers for Disease Control and Prevention (CDC) in FY 2022. The funds address childhood lead poisoning prevention and surveillance programmatic activities being conducted from September 30, 2022 to September 29, 2023.
\nThe strategies focus on
\nTo learn more about these efforts in Michigan, contact the program below.
\nMichigan Department of Health and Human Services
Childhood Lead Poisoning Prevention Program
235 S Grand Ave. Suite 800
Lansing, MI 48933
Phone: 517-335-8885
Improving Timeliness and Quality of Blood Lead Data Through a Public-Private Partnership in Michigan
\nTimely and accurate blood lead test result reporting is vital to ensuring children with higher blood lead levels receive prompt and comprehensive care. Since 2017, the number of facilities that perform LeadCare II1 testing in healthcare providers\u2019 offices in Michigan has risen significantly to over 300 due to the state\u2019s Childhood Lead Poisoning Prevention Program (CLPPP) efforts to increase blood lead testing of children younger than age 6 years. However, there was not a reliable automated mechanism available to report LeadCare II test results to the CLPPP.
\nA vast majority of clinics report results through an Excel template that requires clinic staff time to manually enter the data and report it to CLPPP. Results from LeadCare II clinics represent 27% of all test results submitted since CLPPP began to track submission type in September 2020. These files also require 15\u201320 hours of manual effort by the CLPPP staff to pre-process and clean before entry into the Michigan Childhood Lead Poisoning Surveillance (MICLPS) application, which causes delays in availability of the results to local health departments and other programs within the state who provide services for children younger than age 6 with higher blood lead levels.
\nAs the time and effort required to process LeadCare II files increased, CLPPP expanded the existing partnership with the Altarum Institute (Altarum) to establish an automated reporting mechanism. Altarum is a nonprofit organization that partners with the State of Michigan to provide health information exchange and other data processing services. In 2017, CLPPP created an HL7 reporting route for clinical labs, which sends results through Altarum\u2019s Rhapsody environment and inserts them directly into MICLPS.
\nCLPPP worked with Altarum in 2021 and 2022 to create a new automated reporting route through Altarum for LeadCare II labs and clinical labs that did not already report through HL7 messaging. This project included the following phases:
\nLabs began to report through the new route in early 2022 and successfully sent messages that were loaded into MICLPS through Altarum.
\nSince the new reporting mechanism for labs was implemented in April 2021, CLPPP has observed the following as of December 2022.
\nCLPPP continues to onboard additional labs. CLPPP has taken lessons learned from this project to streamline onboarding and adjust the required data sharing agreements using feedback from the previously onboarded labs with the hope of reducing the time from kick-off to production for new labs. CLPPP also worked with Altarum to develop a quarterly status report on the project to establish metrics for routine reported.
\n1 Copyright \u00a92022 Meridian Bioscience, Inc. Magellan Diagnostics and LeadCare are registered trademarks of Meridian Bioscience, Inc. All rights reserved. Mention of LeadCare is not an endorsement of this product.
\nFunding for this work was made possible in part by NUE2EH001444from the Centers for Disease Control and Prevention (CDC). The views expressed in this material do not necessarily reflect the official policies of the CDC; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
\nIncreased Capillary to Venous Testing Rates in Kent County, Michigan
\nCapillary tests are a quick and easy way to test blood lead levels (BLLs) but they can be contaminated and deliver false-positive results. A venous test can confirm whether a child with an elevated capillary test result truly has an elevated BLL. Therefore, a major goal of Michigan\u2019s Childhood Lead Poisoning Prevention Program (CLPPP) is to increase capillary to venous testing rates throughout the state.
\nMichigan\u2019s Childhood Lead Poisoning Prevention Program (CLPPP) updated reporting requirements for providers and laboratories. Subsequently, the Kent County Health Department successfully increased capillary to venous testing rates by implementing a follow-up protocol for elevated capillary results in 2017. The protocol includes a timeline for regular communication with the family of a child who has an elevated capillary test result to encourage venous testing.
\nAdditionally, CLPPP staff members visited and contacted local providers to raise awareness about testing and reporting in Kent County, thereby assisting the Kent County Health Department in their efforts.
\nFrom FY2017 through FY2019, the capillary to venous confirmatory rates in Kent County increased from 35% to 72% in 90 days and from 21% to 56% in 30 days. Other counties throughout Michigan are replicating this protocol to increase capillary to venous testing rates statewide.
\nFunding for this work was made possible in part by NUE2EH001390 from the Centers for Disease Control and Prevention (CDC). The views expressed in this material do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
\n